Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Randomised, Controlled Clinical Trial to Asses the Safety of Endobronchial Administration of Allogneic Mesenchymal Stromal Cells in Patients With Lung Trasplant Chronic Rejection: Endosclad Study.

NCT06514378 is registered in ClinicalTrials.gov with Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana as lead sponsor.

NCT NCT06514378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06514378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Randomised, Controlled Clinical Trial to Asses the Safety of Endobronchial Administration of Allogneic Mesenchymal Stromal Cells in Patients With Lung Trasplant Chronic Rejection: Endosclad Study.
Lead sponsor
Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana
Phase
Phase 1
Overall status
Unknown status
Start date
September 19, 2023
Completion date
March 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lung disease, lung transplant rejection